Pharma Exclusives Pressreleases
U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants
Tuesday, June 10, 2025Merckknown as MSD outside of the United States and Canada today announced the US Food and Drug Administration FDA has approved ENFLONSIA clesrovimabcfor for the prevention of respiratory syncytial virus RSV
Merck Announces Positive Topline Results From the First Two Phase 3 CORALreef Trials Evaluating Enlicitide Decanoate for the Treatment of Adults With Hyperlipidemia
Monday, June 09, 2025Merckknown as MSD outside of the United States and Canada today announced positive topline results from the first two of three Phase clinical trials evaluating the safety and efficacy of enlicitide decanoate
Celularity Announces Publication Advancing Ocular Surface Reconstruction with Tri-Layer Amniotic Membrane Technology
Tuesday, June 03, 2025Celularity Inc a regenerative and cellular medicine company today announced its research published in the May issue of the peerreviewed journal Regenerative Engineering and Translational Medicine a leading openaccess journal publishing cuttingedge...
Thermo Fisher Scientific Unveils Next-generation Mass Spectrometers at ASMS 2025 to Revolutionize Biopharma Applications and Omics Research
Tuesday, June 03, 2025Thermo Fisher Scientific Inc the world leader in serving science today announced the launch of the Thermo Scientific Orbitrap Astral Zoom mass spectrometer MS and the Thermo Scientific Orbitrap Excedion
Cybin Announces Additional U.S. Patent Supporting its CYB004 Program in Phase 2 Development for Generalized Anxiety Disorder
Tuesday, June 03, 2025Cybin Inc a clinicalstage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative nextgeneration treatment options
Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
Saturday, May 31, 2025Moderna Inc today announced that the US Food and Drug Administration FDA has approved mNEXSPIKE mRNA a new vaccine against COVID for use in all adults and older as well as individuals
Merck Reports Positive Phase 2 Results for Zilovertamab Vedotin Combined with Standard Treatment in Relapsed/Refractory DLBCL Patients
Friday, May 30, 2025Merck known as MSD outside of the United States and Canada today announced results from the dose confirmation portion of the Phase waveLINE study evaluating zilovertamab vedotin in combination
Pfizer’s BRAFTOVI® Combination Regimen Cuts the Risk of Death in Half for Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer
Friday, May 30, 2025Pfizer Inctoday announced statistically significant and clinically meaningful survival results from the Phase BREAKWATER trial evaluating BRAFTOVI encorafenib in combination with cetuximab marketed as ERBITUX and mFOLFOX fluorouracil leucovorin and...
Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution
Thursday, May 29, 2025Eton Pharmaceuticals Inc an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases today announced the US Food and Drug Administration FDA approval of a New Drug Application
Patritumab Deruxtecan Biologics License Application for Patients With Previously Treated Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer Voluntarily Withdrawn
Thursday, May 29, 2025The Biologics License Application BLA seeking accelerated approval in the US for Daiichi Sankyo TSE and Mercks NYSE MRK known as MSD outside of the United States and Canada patritumab deruxtecan HERDXd based on the HERTHENALung Phase trial for the...
